House dust mite sublingual immunotherapy reduces symptoms, decreases medication use, and shows a favorable safety profile in ...

Rising diagnoses of young onset dementia highlight the need for early recognition and timely evaluation of a condition that disrupts patients’ careers, families, and financial stability.

A large UK pragmatic trial found that regulatory clearance based on accuracy does not ensure clinical benefit when adoption by clinicians remains limited in routine practice.

A systematic review found that patients with autoimmune liver diseases had altered oral microbiota — notably increased Veillonella — which in some studies was associated with elevated salivary ...

From 2016-2025, the co-involvement of stimulants in fentanyl overdose deaths increased 164%, according to a new report by Millennium Health, a San Diego-based specialty lab that conducts urine drug ...

A new study indicated that the Bellmunt Risk Score can help stratify survival outcomes in patients with metastatic castration-resistant prostate cancer. Using data from more than 1700 patients across ...

Kids with numerous dental problems and severe gingivitis were up to 45% more likely to have a heart attack, stroke, or coronary artery disease as adults than kids with less oral disease.

Phase 3 trial data show that obinutuzumab significantly reduces disease activity in very active extrarenal lupus.

The availability of TNF inhibitor biosimilars and the cost of treating ‘difficult-to-treat’ RA are making first-line TNF inhibition in early RA more attractive in the UK.

Although a majority of patients with cerebral venous sinus thrombosis achieve independence, 1 in 3 may develop delayed complications such as seizures, a study shows.

A case series reports dysesthesia and allodynia in patients treated with semaglutide and tirzepatide, suggesting a possible dose related to sensory adverse effect.

Digitally delivered behavior-change prompts plus short videos boosted GLP-1 users’ expectations to adopt healthy lifestyle behaviors in a new, early-stage randomized clinical trial. “What surprised us ...